SCD and lung adenocarcinoma: Meanwhile, another one of their studies confirmed that the expression of SCD1 was associated with a poor prognosis in lung adenocarcinoma, and inhibiting the activity of SCD1 reversed resistance to cisplatin in lung CSCs (Pisanu et al., 2017).